JNJ's 62-year streak of dividend growth, 3.4% yield, and disciplined capital allocation make it highly attractive for ...

For generations of Americans the Johnson & Johnson brand has been a beloved one, as quintessentially American as baseball and ...

Johnson & Johnson's recent earnings beat expectations, with strong Medicine and MedTech growth. Read why I have a buy rating ...